Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole S Arellano

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Elife|November 6, 2024
Predicting drug resistanceNicole S Arellano, Shannon E Elf
Blood Neoplasia|March 9, 2026
Mutant calreticulin-directed immunotherapies in myeloproliferative neoplasmsWilliam L Heaton, Matthew T Jenkins, Nicole S Arellano, et al.
Blood Cancer Discovery|April 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative NeoplasmsJuan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz, et al.
Blood|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasmsNicole S Arellano, William L Heaton, Mirielle C Nauman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Elife|November 6, 2024
Predicting drug resistanceNicole S Arellano, Shannon E Elf
Blood Neoplasia|March 9, 2026
Mutant calreticulin-directed immunotherapies in myeloproliferative neoplasmsWilliam L Heaton, Matthew T Jenkins, Nicole S Arellano, et al.
Blood Cancer Discovery|April 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative NeoplasmsJuan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz, et al.
Blood|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasmsNicole S Arellano, William L Heaton, Mirielle C Nauman, et al.
Pageof 1